Vars-based apollogreen has received the Health Canada licences it needs to starting using industrial-scale tissue culture to produce millions of starter plants for cannabis growers, the firm announced Thursday.

The company will start work on a 5,000-square-foot facility and begin securing financing for a 70,000-square-foot building.

It’s “open for investment” with “one of the largest cannabis genetic catalogues in the world” totalling more than 350 varieties, the firm says in a release announcing that it has received licences for cultivation, processing and medical sales.

– Read the entire article at Ottawa Citizen.